Study Age a Type of Vascular Anomaly Location of Vascular Anomaly Type of Infection Co-Administered Steroids Sirolimus (Trough or Target) Time after starting sirolimus Antibiotic Prophylaxis
Hammill 20119 10 months old KHE with KMP Abdomen, back, chest, left leg, pelvis, retroperitoneum Central Line Infection after RSV and Flu respiratory distress Steroid burst Target 10-15 ng/ml N.S. PJP prophylaxis
Rossler 202118 2 years old KHE Retroperitoneal with mediastinal extension Central Line Infection, staph epidermidis N.S. Trough 6.5 ng/ml 5 months PJP prophylaxis
Sandbank 201932 N.S. N.S. N.S. Bacteremia, MRSA N.S. N.S. N.S. N.S.
Maruani 202120 N.S. Slow flow vascular malformation N.S. Bacteremia, Pseudomonas aeruginosa N.S. Target 4 – 12 ng/ml N.S. None